NEUKF Financials Tuesday, July 15, 2014 06:28:28 A
Post# of 52
Neurokine Pharmaceuticals Inc.
Period Ending Jan 31, 2014 Jun 30, 2013 Jan 31, 2013 Jan 31, 2012
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - 58
Sales, General and Admin. 41 - 89 300
Non-Recurring Items - - - -
Other - - - -
Operating Income (69) - (89) (361)
Income From Continuing Operations
Add'l Income/Expense Items (547) - 456 2,139
Earnings Before Interest and Tax (588) - 366 1,781
Interest Expense 88 - 24 367
Earnings Before Tax (676) - 342 1,414
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (676) - 342 1,414
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (676) - 342 1,414
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (676) - 342 1,414